• Explore /
  • Poster
  • / Efficacy and safety of entrectinib in patients (pts) with <em>NTRK</em>-fusion positive (<em>NTRK</em>-fp) solid tumors: An updated integrated analysis.

Efficacy and safety of entrectinib in patients (pts) with NTRK-fusion positive (NTRK-fp) solid tumors: An updated integrated analysis.

Abstract Video & Slides Poster

Authors

Christian Rolfo

Christian Diego Rolfo

University of Maryland School of Medicine, Baltimore, MD

Christian Diego Rolfo , Filippo G. De Braud , Robert Charles Doebele , Alexander E. Drilon , Salvatore Siena , Manish Patel , Byoung Chul Cho , Stephen V. Liu , Myung-Ju Ahn , Chao-Hua Chiu , Anna F. Farago , Koichi Goto , Jeeyun Lee , Lyudmila Bazhenova , Tom John , Marwan Fakih , Brian P. Simmons , Bethany Pitcher , Xinhui Huang , George D. Demetri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT02097810, NCT02568267

Citation

J Clin Oncol 38: 2020 (suppl; abstr 3605)

DOI

10.1200/JCO.2020.38.15_suppl.3605

Abstract #

3605

Poster Bd #

335

Abstract Disclosures

Similar Posters

First Author: Salvatore Siena

First Author: Shubham Pant

First Author: Luis G. Paz-Ares

First Author: Misako Nagasaka